
Michael Nakazawa
Physician · University of Texas M D Anderson Cancer Center
Credentials: · · · · · ·
History
- 2023–Present

- 2013–2017
Doctor of Medicine
Research
Oxygen availability and metabolic adaptations
Review · Nature reviews. Cancer · 2016 · First of 3 authors · 333 citations
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma
Clinical Cancer Research · 2013 · 324 citations
Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis
Cancer Discovery · 2013 · 232 citations

10 papers · 5 as a fellow

9 papers

8 papers

7 papers · 7 as a resident

7 papers

6 papers

6 papers

6 papers
Clinical trials
- 2026–2029
Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
- 2026–2030
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
- 2025–2032
Actinium Therapy for Late-stage Aggressive Sarcomas
Site PI · Recruiting · Phase 1
Ratio Therapeutics, Inc.
- 2024–2027
Site PI · Recruiting · Phase 1
Angiex, Inc.



